Read More Pharma Industry News Roche’s breast cancer pill inavolisib approved by MHRA for metastatic disease MHRA approves inavolisib for advanced HR-positive breast cancer. Find out how Roche’s targeted therapy expands treatment options for UK patients. byVenkateshNovember 27, 2025